Acute liver failure and liver transplantation

Intractable and Rare Diseases Research

Volumn 2, Issue 3, 2013, Pages 77-87

  Akamatsu, Nobuhisa ^a   Sugawara, Yasuhiko ^b   Kokudo, Norihiro ^b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

(LDLT); Acute liver failure; liver transplantation; living donor liver transplantation; optimal graft volume; treatment

Indexed keywords

EID: 85008682369     PISSN: 21863644     EISSN: 2186361x     Source Type: Journal    
DOI: 10.5582/irdr.2013.v2.3.77     Document Type: Article

References (130)

1. Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet. 2010; 376:190-201.
2. Lee W.M. Recent developments in acute liver failure. Best Pract Res Clin Gastroenterol. 2012; 26:3-16.
3. Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle J.H. Acute liver failure: Summary of a workshop. Hepatology. 2008; 47:1401-1415.
4. Lee WM, Stravitz RT, Larson A.M. Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. Hepatology. 2012; 55:965-967.
5. Bernuau J, Rueff B, Benhamou J.P. Fulminant and subfulminant liver failure: Definitions and causes. Semin Liver Dis. 1986; 6:97-106.
6. Bernal W, Hyyrylainen A, Gera A, Audimoolam VK, McPhail MJ, Auzinger G, Rela M, Heaton N, O'Grady JG, Wendon J, Williams R. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol. 2013; 59:74-80.
7. Germani G, Theocharidou E, Adam R, et al. Liver transplantation for acute liver failure in Europe: Outcomes over 20 years from the ELTR database. J Hepatol. 2012; 57:288-296.
8. Liou IW, Larson A.M. Role of liver transplantation in acute liver failure. Semin Liver Dis. 2008; 28:201-209.
9. O'Grady J. Liver transplantation for acute liver failure. Best Pract Res Clin Gastroenterol. 2012; 26:27-33.
10. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002; 137:947-954.
11. Trey C, Davidson C.S. The management of fulminant hepatic failure. Prog Liver Dis. 1970; 3:282-298.
12. O'Grady JG, Schalm SW, Williams R. Acute liver failure: Redefining the syndromes. Lancet 1993; 342:273-275.
13. O'Grady JG, Williams R. Classification of acute liver failure. Lancet. 1993; 342:743.
14. Bower WA, Johns M, Margolis HS, Williams IT, Bell B.P. Population-based surveillance for acute liver failure. Am J Gastroenterol. 2007; 102:2459-2463.
15. Brandsaeter B, Höckerstedt K, Friman S, Ericzon BG, Kirkegaard P, Isoniemi H, Olausson M, Broome U, Schmidt L, Foss A, Bjøro K. Fulminant hepatic failure: Outcome after listing for highly urgent liver transplantation-12 years experience in the nordic countries. Liver Transpl. 2002; 8:1055-1062.
16. Oketani M, Ido A, Nakayama N, Takikawa Y, Naiki T, Yamagishi Y, Ichida T, Mochida S, Onishi S, Tsubouchi H; Intractable Hepato-Biliary Diseases Study Group of Japan. Etiology and prognosis of fulminant hepatitis and late-onset hepatic failure in Japan: Summary of the annual nationwide survey between 2004 and 2009. Hepatol Res. 2013; 43:97-105.
17. Hoofnagle JH, Carithers RL Jr, Shapiro C, Ascher N. Fulminant hepatic failure: Summary of a workshop. Hepatology. 1995; 21:240-252.
18. Sass DA, Shakil A.O. Fulminant hepatic failure. Liver Transpl. 2005; 11:594-605.
19. Acharya SK, Dasarathy S, Kumer TL, Sushma S, Prasanna KS, Tandon A, Sreenivas V, Nijhawan S, Panda SK, Nanda SK, Irshad M, Joshi YK, Duttagupta S, Tandon RK, Tandon B.N. Fulminant hepatitis in a tropical population: Clinical course, cause, and early predictors of outcome. Hepatology. 1996; 23:1448-1455.
20. Mudawi HM, Yousif B.A. Fulminant hepatic failure in an African setting: Etiology, clinical course, and predictors of mortality. Dig Dis Sci. 2007; 52:3266-3269.
21. Bernal W, Auzinger G, Wendon J. Prognostic utility of the bilirubin lactate and etiology score. Clin Gastroenterol Hepatol. 2009; 7:249.
22. Hadem J, Tacke F, Bruns T, Langgartner J, Strnad P, Denk GU, Fikatas P, Manns MP, Hofmann WP, Gerken G, Grünhage F, Umgelter A, Trautwein C, Canbay A; Acute Liver Failure Study Group Germany. Etiologies and outcomes of acute liver failure in Germany. Clin Gastroenterol Hepatol. 2012; 10:664-669 e2.
23. Jin YJ, Lim YS, Han S, Lee HC, Hwang S, Lee S.G. Predicting survival after living and deceased donor liver transplantation in adult patients with acute liver failure. J Gastroenterol. 2012; 47:1115-1124.
24. Khuroo MS, Kamili S. Aetiology and prognostic factors in acute liver failure in India. J Viral Hepat. 2003; 10:224-231.
25. Polson J, Lee WM; American Association for the Study of Liver Disease. AASLD position paper: The management of acute liver failure. Hepatology. 2005; 41:1179-1197.
26. Chung RT, Stravitz RT, Fontana RJ, Schiodt FV, Mehal WZ, Reddy KR, Lee W.M. Pathogenesis of liver injury in acute liver failure. Gastroenterology. 2012; 143:e1-e7.
27. Bernal W, Auzinger G, Sizer E, Wendon J. Intensive care management of acute liver failure. Semin Liver Dis. 2008; 28:188-200.
28. Stravitz RT, Kramer AH, Davern T, Shaikh AO, Caldwell SH, Mehta RL, Blei AT, Fontana RJ, McGuire BM, Rossaro L, Smith AD, Lee WM; Acute Liver Failure Study Group. Intensive care of patients with acute liver failure: Recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med. 2007; 35:2498-2508.
29. Vaquero J, Butterworth R.F. Mechanisms of brain edema in acute liver failure and impact of novel therapeutic interventions. Neurol Res. 2007; 29:683-690.
30. Bjerring PN, Eefsen M, Hansen BA, Larsen F.S. The brain in acute liver failure. A tortuous path from hyperammonemia to cerebral edema. Metab Brain Dis. 2009; 24:5-14.
31. Bhatia V, Singh R, Acharya S.K. Predictive value of arterial ammonia for complications and outcome in acute liver failure. Gut. 2006; 55:98-104.
32. Bernal W, Hall C, Karvellas CJ, Auzinger G, Sizer E, Wendon J. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology. 2007; 46:1844-1852.
33. Ede RJ, Williams R.W. Hepatic encephalopathy and cerebral edema. Semin Liver Dis. 1986; 6:107-118.
34. Gazzard BG, Portmann B, Murray-Lyon IM, Williams R. Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage. Q J Med. 1975; 44:615-626.
35. Lidofsky SD, Bass NM, Prager MC, Washington DE, Read AE, Wright TL, Ascher NL, Roberts JP, Scharschmidt BF, Lake J.R. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology. 1992; 16:1-7.
36. Vaquero J, Fontana RJ, Larson AM, Bass NM, Davern TJ, Shakil AO, Han S, Harrison ME, Stravitz TR, MuǸoz S, Brown R, Lee WM, Blei A.T. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl. 2005; 11:1581-1589.
37. Ellis AJ, Wendon JA, Williams R. Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: A controlled clinical trial. Hepatology. 2000; 32:536-541.
38. Murphy N, Auzinger G, Bernel W, Wendon J. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology. 2004; 39:464-470.
39. Canalese J, Gimson AE, Davis C, Mellon PJ, Davis M, Williams R. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut. 1982; 23:625-629.
40. Vaquero J. Therapeutic hypothermia in the management of acute liver failure. Neurochem Int. 2012; 60:723-735.
41. Sekido H, Matsuo K, Takeda K, Ueda M, Morioka D, Kubota T, Tanaka K, Endo I, Togo S, Shimada H. Usefulness of artificial liver support for pretransplant patients with fulminant hepatic failure. Transplant Proc. 2004; 36:2355-2356.
42. O'Grady JG, Langley PG, Isola LM, Aledort LM, Williams R. Coagulopathy of fulminant hepatic failure. Semin Liver Dis. 1986; 6:159-163.
43. Gazzard BG, Clark R, Borirakchanyavat V, Williams R. A controlled trial of heparin therapy in the coagulation defect of paracetamol-induced hepatic necrosis. Gut. 1974; 15:89-93.
44. MacDougall BR, Williams R. H2-receptor antagonist in the prevention of acute upper gastrointestinal hemorrhage in fulminant hepatic failure: A controlled trial. Gastroenterology. 1978; 74:464-465.
45. Hugenholtz GC, Adelmeijer J, Meijers JC, Porte RJ, Stravitz RT, Lisman T. An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: Implications for hemostasis and clinical outcome. Hepatology. 2013; 58:752-761.
46. Stravitz RT, Lisman T, Luketic VA, Sterling RK, Puri P, Fuchs M, Ibrahim A, Lee WM, Sanyal A.J. Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol. 2012; 56:129-136.
47. Gazzard BG, Henderson JM, Williams R. Early changes in coagulation following a paracetamol overdose and a controlled trial of fresh frozen plasma therapy. Gut. 1975; 16:617-620.
48. Bihari DJ, Gimson AE, Williams R. Cardiovascular, pulmonary and renal complications of fulminant hepatic failure. Semin Liver Dis. 1986; 6:119-128.
49. Ring-Larsen H, Palazzo U. Renal failure in fulminant hepatic failure and terminal cirrhosis: A comparison between incidence, types, and prognosis. Gut. 1981; 22:585-591.
50. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989; 97:439-445.
51. Jain S, Pendyala P, Varma S, Sharma N, Joshi K, Chawla Y. Effect of renal dysfunction in fulminant hepatic failure. Trop Gastroenterol. 2000; 21:118-120.
52. Davenport A, Will EJ, Davidson A.M. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med. 1993; 21:328-338.
53. Schneeweiss B, Pammer J, Ratheiser K, et al. Energy metabolism in acute hepatic failure. Gastroenterology. 1993; 105:1515-1521.
54. Vaquero J, Polson J, Chung C, Helenowski I, Schiodt FV, Reisch J, Lee WM, Blei A.T. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology. 2003; 125:755-764.
55. Rolando N, Harvey F, Brahm J, Philpott-Howard J, Alexander G, Casewell M, Fagan E, Williams R. Fungal infection: A common, unrecognised complication of acute liver failure. J Hepatol. 1991; 12:1-9.
56. Rolando N, Harvey F, Brahm J, Philpott-Howard J, Alexander G, Gimson A, Casewell M, Fagan E, Williams R. Prospective study of bacterial infection in acute liver failure: An analysis of fifty patients. Hepatology. 1990; 11:49-53.
57. Rolando N, Philpott-Howard J, Williams R. Bacterial and fungal infection in acute liver failure. Semin Liver Dis. 1996; 16:389-402.
58. Wade JJ, Rolando N, Hayllar K, Philpott-Howard J, Casewell MW, Williams R. Bacterial and fungal infections after liver transplantation: An analysis of 284 patients. Hepatology. 1995; 21:1328-1336.
59. Canalese J, Gove CD, Gimson AE, Wilkinson SP, Wardle EN, Williams R. Reticuloendothelial system and hepatocytic function in fulminant hepatic failure. Gut. 1982; 23:265-269.
60. Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology. 2000; 32:734-739.
61. Samuel D, Bismuth H. Transplantation in patients with fulminant hepatitis. In: Transplantation of the Liver, 3rd Edition (Maddrey W, Schiff E, Sorrell M, Eds). Lippincott Williams & Williams, Philadelphia, USA, 2001; pp. 361-370.
62. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: Clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl. 2000; 6:163-169.
63. Bismuth H, Samuel D, Castaing D, Adam R, Saliba F, Johann M, Azoulay D, Ducot B, Chiche L. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg. 1995; 222:109-119.
64. Wlodzimirow KA, Eslami S, Chamuleau RA, Nieuwoudt M, Abu-Hanna A. Prediction of poor outcome in patients with acute liver failure-systematic review of prediction models. PLoS One. 2012; 7:e50952.
65. Bernuau J, Goudeau A, Poynard T, Dubois F, Lesage G, Yvonnet B, Degott C, Bezeaud A, Rueff B, Benhamou J.P. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology. 1986; 6:648-651.
66. Yantorno SE, Kremers WK, Ruf AE, Trentadue JJ, Podesta LG, Villamil F.G. MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure. Liver Transpl. 2007; 13:822-828.
67. Mitchell I, Bihari D, Chang R, Wendon J, Williams R. Earlier identification of patients at risk from acetaminophen-induced acute liver failure. Crit Care Med. 1998; 26:279-284.
68. Mochida S, Nakayama N, Matsui A, Nagoshi S, Fujiwara K. Re-evaluation of the Guideline published by the Acute Liver Failure Study Group of Japan in 1996 to determine the indications of liver transplantation in patients with fulminant hepatitis. Hepatol Res. 2008; 38:970-979.
69. Takahashi Y, Kumada H, Shimizu M, et al. A multicenter study on the prognosis of fulminant viral hepatitis: Early prediction for liver transplantation. Hepatology. 1994; 19:1065-1071.
70. Yoshiba M, Sekiyama K, Inoue K, Yamada M, Kako M, Nagai K, Takatori M, Iwabuchi S, Sumino Y, Tanaka K, Hakozaki Y, Hasegawa K, Shibuya A. Accurate prediction of fulminant hepatic failure in severe acute viral hepatitis: Multicenter study. J Gastroenterol. 2002; 37:916-921.
71. Akamatsu N, Sugawara Y. Acute liver failure and living donor liver transplantation. Hepatol Res. 2008; 38 (Suppl 1):S60-S71.
72. Bailey B, Amre DK, Gaudreault P. Fulminant hepatic failure secondary to acetaminophen poisoning: A systematic review and meta-analysis of prognostic criteria determining the need for liver transplantation. Crit Care Med. 2003; 31:299-305.
73. McPhail MJ, Wendon JA, Bernal W. Meta-analysis of performance of Kings's College Hospital Criteria in prediction of outcome in non-paracetamol-induced acute liver failure. J Hepatol. 2010; 53:492-499.
74. Craig DG, Ford AC, Hayes PC, Simpson K.J. Systematic review: Prognostic tests of paracetamol-induced acute liver failure. Aliment Pharmacol Ther. 2010; 31:1064-1076.
75. Schmidt LE, Larsen F.S. MELD score as a predictor of liver failure and death in patients with acetaminopheninduced liver injury. Hepatology. 2007; 45:789-796.
76. Zaman MB, Hoti E, Qasim A, Maguire D, McCormick PA, Hegarty JE, Geoghegan JG, Traynor O. MELD score as a prognostic model for listing acute liver failure patients for liver transplantation. Transplant Proc. 2006; 38:2097-2098.
77. Bechmann LP, Jochum C, Kocabayoglu P, Sowa JP, Kassalik M, Gieseler RK, Saner F, Paul A, Trautwein C, Gerken G, Canbay A. Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury. J Hepatol. 2010; 53:639-647.
78. Miyake Y, Sakaguchi K, Iwasaki Y, Ikeda H, Makino Y, Kobashi H, Araki Y, Ando M, Kita K, Shiratori Y. New prognostic scoring model for liver transplantation in patients with non-acetaminophen-related fulminant hepatic failure. Transplantation. 2005; 80:930-936.
79. Schiùdt FV, Ostapowicz G, Murray N, Satyanarana R, Zaman A, Munoz S, Lee W.M. Alpha-fetoprotein and prognosis in acute liver failure. Liver Transpl. 2006;12:1776-1781.
80. Schmidt LE, Dalhoff K. Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity. Hepatology. 2002; 36:659-665.
81. Chung PY, Sitrin MD, Te H.S. Serum phosphorus levels predict clinical outcome in fulminant hepatic failure. Liver Transpl. 2003; 9:248-253.
82. Shakil AO, Jones BC, Lee RG, Federle MP, Fung JJ, Rakela J. Prognostic value of abdominal CT scanning and hepatic histopathology in patients with acute liver failure. Dig Dis Sci. 2000; 45:334-339.
83. Itai Y, Sekiyama K, Ahmadi T, Obuchi M, Yoshiba M. Fulminant hepatic failure: Observation with serial C.T. Radiology. 1997; 202:379-382.
84. Yamagishi Y, Saito H, Ebinuma H, Kikuchi M, Ojiro K, Kanamori H, Tada S, Horie Y, Kato S, Hibi T. A new prognostic formula for adult acute liver failure using computer tomography-derived hepatic volumetric analysis. J Gastroenterol. 2009; 44:615-623.
85. Monoe T, Nomura T, Nakao H, Sobue S, Mizuno Y, Nojiri S, Kanematsu T, Senda K, Ohmi H, Ohara H, Joh T, Itoh K, Itoh M. Prognostic indicators estimated by (99m)Tc-GSA in acute liver damage. Hepatol Res. 2005; 31:153-159.
86. Nagaki M, Iwai H, Naiki T, Ohnishi H, Muto Y, Moriwaki H. High levels of serum interleukin-10 and tumor necrosis factor-alpha are associated with fatality in fulminant hepatitis. J Infect Dis. 2000; 182:1103-1108.
87. Macquillan GC, Seyam MS, Nightingale P, Neuberger JM, Murphy N. Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure. Liver Transpl. 2005; 11:1073-1079.
88. Bernal W. Lactate is important in determining prognosis in acute liver failure. J Hepatol. 2010; 53:209-210.
89. Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamolinduced acute liver failure: A cohort study. Lancet. 2002; 359:558-563.
90. — 2009 Annual report of the U.S. organ procurement and transplantation network and the scientific registry of transplant recipients: Transplant data 1999-2008. U.S. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation. http://www.ustransplant.org/annual_reports/current (accessed July 1, 2013).
91. Hanto DW, Fishbein TM, Pinson CW, Olthoff KM, Shiffman ML, Punch JD, Goodrich N.P. Liver and intestine transplantation: Summary analysis, 1994-2003. Am J Transplant. 2005; 5:916-933.
92. Adam R, McMaster P, O'Grady JG, et al. Evolution of liver transplantation in Europe: Report of the European Liver Transplant Registry. Liver Transpl. 2003; 9:1231-1243.
93. Bernal W, Cross TJ, Auzinger G, Sizer E, Heneghan MA, Bowles M, Muiesan P, Rela M, Heaton N, Wendon J, O'Grady J.G. Outcome after wait-listing for emergency liver transplantation in acute liver failure: A single centre experience. J Hepatol. 2009; 50:306-313.
94. Eghtesad B, Bronsther O, Irish W, Casavilla A, Abu-Elmagd K, Van Thiel D, Tzakis A, Fung JJ, Starzl T.E. Disease gravity and urgency of need as guidelines for liver allocation. Hepatology. 1994; 20:56S-62S.
95. Wigg AJ, Gunson BK, Mutimer D.J. Outcomes following liver transplantation for seronegative acute liver failure: Experience during a 12-year period with more than 100 patients. Liver Transpl. 2005; 11:27-34.
96. Farmer DG, Anselmo DM, Ghobrial RM, et al. Liver transplantation for fulminant hepatic failure: Experience with more than 200 patients over a 17-year period. Ann Surg. 2003; 237:666-675; discussion 675-676.
97. Chan G, Taqi A, Marotta P, Levstik M, McAlister V, Wall W, Quan D. Long-term outcomes of emergency liver transplantation for acute liver failure. Liver Transpl. 2009; 15:1696-1702.
98. Barshes NR, Lee TC, Balkrishnan R, Karpen SJ, Carter BA, Goss J.A. Risk stratification of adult patients undergoing orthotopic liver transplantation for fulminant hepatic failure. Transplantation. 2006; 81:195-201.
99. Burroughs AK, Sabin CA, Rolles K, et al. 3-month and 12-month mortality after first liver transplant in adults in Europe: Predictive models for outcome. Lancet. 2006; 367:225-232.
100. Detre K, Belle S, Beringer K, Daily O.P. Liver transplantation for fulminant hepatic failure in the United States: October 1987 through December 1991. Clin Transplant. 1994; 8:274-280.
101. Toso C, Al-Qahtani M, Alsaif FA, Bigam DL, Meeberg GA, James Shapiro AM, Bain VG, Kneteman N.M. ABO-incompatible liver transplantation for critically ill adult patients. Transpl Int. 2007; 20:675-681.
102. Bjøro K, Ericzon BG, Kirkegaard P, Höckerstedt K, Söderdahl G, Olausson M, Foss A, Schmidt LE, Isoniemi H, Brandsaeter B, Friman S. Highly urgent liver transplantation: Possible impact of donor-recipient ABO matching on the outcome after transplantation. Transplantation. 2003; 75:347-353.
103. Farges O, Kalil AN, Samuel D, Saliba F, Arulnaden JL, Debat P, Bismuth A, Castaing D, Bismuth H. The use of ABO-incompatible grafts in liver transplantation: A life-saving procedure in highly selected patients. Transplantation. 1995; 59:1124-1133.
104. de Villa VH, Lo CM, Chen C.L. Ethics and rationale of living-donor liver transplantation in Asia. Transplantation. 2003; 75(3 Suppl):S2-S5.
105. Yamashiki N, Sugawara Y, Tamura S, Nakayama N, Oketani M, Umeshita K, Uemoto S, Mochida S, Tsubouchi H, Kokudo N. Outcomes after living donor liver transplantation for acute liver failure in Japan: Results of a nationwide survey. Liver Transpl. 2012; 18:1069-1077.
106. Kato T, Nery JR, Morcos JJ, Gyamfi AR, Ruiz P, Molina EG, Tzakis A.G. Successful living related liver transplantation in an adult with fulminant hepatic failure. Transplantation. 1997; 64:415-417.
107. Uemoto S, Inomata Y, Sakurai T, Egawa H, Fujita S, Kiuchi T, Hayashi M, Yasutomi M, Yamabe H, Tanaka K. Living donor liver transplantation for fulminant hepatic failure. Transplantation. 2000; 70:152-157.
108. Carlisle EM, Angelos P, Siegler M, Testa G. Adult living-related liver donation for acute liver failure: Is it ethically appropriate? Clin Transplant. 2011; 25:813-820.
109. Liu CL, Fan ST, Lo CM, Yong BH, Fung AS, Wong J. Right-lobe live donor liver transplantation improves survival of patients with acute liver failure. Br J Surg. 2002; 89:317-322.
110. Park SJ, Lim YS, Hwang S, Heo NY, Lee HC, Suh DJ, Yu E, Lee S.G. Emergency adult-to-adult living-donor liver transplantation for acute liver failure in a hepatitis B virus endemic area. Hepatology. 2010; 51:903-911.
111. Ikegami T, Taketomi A, Soejima Y, Yoshizumi T, Sanefuji K, Kayashima H, Shimada M, Maehara Y. Living donor liver transplantation for acute liver failure: A 10-year experience in a single center. J Am Coll Surg 2008; 206:412-418.
112. Matsui Y, Sugawara Y, Yamashiki N, Kaneko J, Tamura S, Togashi J, Makuuchi M, Kokudo N. Living donor liver transplantation for fulminant hepatic failure. Hepatol Res. 2008; 38:987-996.
113. Kilic M, Aydin U, Noyan A, Arikan C, Aydogdu S, Akyildiz M, Karasu Z, Zeytunlu M, Alper M, Batur Y. Live donor liver transplantation for acute liver failure. Transplantation. 2007; 84:475-479.
114. Wu YM, Ho MC, Hu RH, Ko WJ, Yang PM, Lai MY, Lee P.H. Liver transplantation for acute hepatic failure. Transplant Proc. 2004; 36:2226-2227.
115. Miwa S, Hashikura Y, Mita A, Kubota T, Chisuwa H, Nakazawa Y, Ikegami T, Terada M, Miyagawa S, Kawasaki S. Living-related liver transplantation for patients with fulminant and subfulminant hepatic failure. Hepatology. 1999; 30:1521-1526.
116. Yuan D, Liu F, Wei YG, Li B, Yan LN, Wen TF, Zhao JC, Zeng Y, Chen K.F. Adult-to-adult living donor liver transplantation for acute liver failure in China. World J Gastroenterol. 2012; 18:7234-7241.
117. Bronster DJ, Emre S, Boccagni P, Sheiner PA, Schwartz ME, Miller C.M. Central nervous system complications in liver transplant recipients ? incidence, timing, and longterm follow-up. Clin Transplant. 2000; 14:1-7.
118. Wright L, Faith K, Richardson R, Grant D; Joint Centre for Bioethics, University of Toronto, Toronto, Ont. Ethical guidelines for the evaluation of living organ donors. Can J Surg. 2004; 47:408-413.
119. Marcos A, Ham JM, Fisher RA, Olzinski AT, Shiffman ML, Sanyal AJ, Luketic VA, Sterling RK, Posner M.P. Emergency adult to adult living donor liver transplantation for fulminant hepatic failure. Transplantation. 2000; 69:2202-2205.
120. Northup PG, Berg C.L. Living donor liver transplantation: The historical and cultural basis of policy decisions and ongoing ethical questions. Health Policy. 2005; 72:175-185.
121. Sugawara Y, Makuuchi M. Living donor liver transplantation: Present status and recent advances. Br Med Bull. 2005; 75-76:15-28.
122. Adams PL, Cohen DJ, Danovitch GM, et al. The nondirected live-kidney donor: Ethical considerations and practice guidelines: A National Conference Report. Transplantation. 2002; 74:582-589.
123. Saidi RF, Jabbour N, Li Y, Shah SA, Bozorgzadeh A. Is left lobe adult-to-adult living donor liver transplantation ready for widespread use? The US experience (1998-2010). HPB (Oxford). 2012; 14:455-460.
124. Ghobrial RM, Freise CE, Trotter JF, Tong L, Ojo AO, Fair JH, Fisher RA, Emond JC, Koffron AJ, Pruett TL, Olthoff KM; A2ALL Study Group. Donor morbidity after living donation for liver transplantation. Gastroenterology. 2008; 135:468-476.
125. Shin M, Song S, Kim JM, Kwon CH, Kim SJ, Lee SK, Joh J.W. Donor morbidity including biliary complications in living-donor liver transplantation: Single-center analysis of 827 cases. Transplantation. 2012; 93:942-948.
126. Barr ML, Belghiti J, Villamil FG, Pomfret EA, Sutherland DS, Gruessner RW, Langnas AN, Delmonico F.L. A report of the Vancouver Forum on the care of the live organ donor: Lung, liver, pancreas, and intestine data and medical guidelines. Transplantation. 2006; 81:1373-1385.
127. Neuberger J, Farber L, Corrado M, O'Dell C. Living liver donation: A survey of the attitudes of the public in Great Britain. Transplantation. 2003; 76:1260-1264.
128. Lo CM, Fan ST, Chan JK, Wei W, Lo RJ, Lai C.L. Minimum graft volume for successful adult-to-adult living donor liver transplantation for fulminant hepatic failure. Transplantation. 1996; 62:696-698.
129. Lee SG, Ahn CS, Kim K.H. Which types of graft to use in patients with acute liver failure? (A) Auxiliary liver transplant (B) Living donor liver transplantation (C) The whole liver. (B) I prefer living donor liver transplantation. J Hepatol. 2007; 46:574-578.
130. Campsen J, Blei AT, Emond JC, Everhart JE, Freise CE, Lok AS, Saab S, Wisniewski KA, Trotter JF; Adult-toAdult Living Donor Liver Transplantation Cohort Study Group. Outcomes of living donor liver transplantation for acute liver failure: The adult-to-adult living donor liver transplantation cohort study. Liver Transpl. 2008; 14:1273-1280